Location History:
- Detroit, MI (US) (2011)
- West Bloomfield, MI (US) (2011 - 2017)
- Southfield, MI (US) (2013 - 2020)
Company Filing History:
Years Active: 2011-2020
Title: Michael A. Tainsky: Innovator in Ovarian Cancer Detection
Introduction
Michael A. Tainsky is a prominent inventor based in West Bloomfield, MI (US). He has made significant contributions to the field of cancer research, particularly in the detection and prediction of ovarian cancer recurrence. With a total of 9 patents to his name, Tainsky's work has the potential to impact the lives of many patients.
Latest Patents
Tainsky's latest patents include groundbreaking technologies aimed at improving ovarian cancer diagnostics. One of his notable inventions is a detector of serum biomarkers for predicting ovarian cancer recurrence. This includes polypeptide marker antigens that specifically bind to autoantibody markers associated with ovarian cancer recurrence. Additionally, he has developed an antibody binding assay for detecting these biomarkers and methods for performing the assay. His work also encompasses methods for determining ovarian cancer recurrence in patients and isolating antibodies specific to ovarian cancer. Another significant patent involves neoepitope detection of disease using protein arrays, which includes a biosensor for detecting disease markers. Furthermore, he has created informatics software for analyzing these arrays, enhancing the efficiency of disease detection.
Career Highlights
Throughout his career, Tainsky has worked with esteemed institutions, including Wayne State University. His research has focused on innovative approaches to cancer detection, contributing to advancements in medical diagnostics.
Collaborations
Tainsky has collaborated with notable colleagues such as Sorin Draghici and Madhumita Chatterjee, further enriching his research endeavors.
Conclusion
Michael A. Tainsky's contributions to ovarian cancer detection and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer diagnostics and patient care.